Related references
Note: Only part of the references are listed.Toll-like receptor (TLR) and inflammasome actions in the central nervous system
Richa Hanamsagar et al.
TRENDS IN IMMUNOLOGY (2012)
Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential
Mark L. Hanke et al.
CLINICAL SCIENCE (2011)
1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis
Christopher G. Mayne et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Influence of 1,25-dihydroxy vitamin D3 on TLR4-induced activation of antigen presenting cells is dependent on the order of receptor engagement
Vandana Gambhir et al.
IMMUNOBIOLOGY (2011)
Predominance of Th2 polarization by Vitamin D through a STAT6-dependent mechanism
Scott Sloka et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Toll-like receptors in cerebral ischemic inflammatory injury
Yan-Chun Wang et al.
JOURNAL OF NEUROINFLAMMATION (2011)
1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A
Sneha Joshi et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration
Joanna Mikita et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Comparative Analysis of Species-Specific Ligand Recognition in Toll-Like Receptor 8 Signaling: A Hypothesis
Rajiv Gandhi Govindaraj et al.
PLOS ONE (2011)
Therapeutic Approaches to Multiple Sclerosis An Update on Failed, Interrupted, or Inconclusive Trials of Immunomodulatory Treatment Strategies
Jochen C. Ulzheimer et al.
BIODRUGS (2010)
C/EBPδ and STAT-1 Are Required for TLR8 Transcriptional Activity
Claudia Zannetti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Toll-Like Receptors Expression and Signaling in Glia Cells in Neuro-Amyloidogenic Diseases: Towards Future Therapeutic Application
Dorit Trudler et al.
MEDIATORS OF INFLAMMATION (2010)
1,25-Dihydroxyvitamin D3 Inhibits the Differentiation and Migration of TH17 Cells to Protect against Experimental Autoimmune Encephalomyelitis
Jae-Hoon Chang et al.
PLOS ONE (2010)
Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes
Laura J. Dickie et al.
RHEUMATOLOGY (2010)
Disease-Modifying Agents in the Treatment of Multiple Sclerosis: A Review of Long-Term Outcomes
Oleksandra Katrych et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Initiation and Progression of Axonopathy in Experimental Autoimmune Encephalomyelitis
Athena M. Soulika et al.
JOURNAL OF NEUROSCIENCE (2009)
TOLL-LIKE RECEPTOR SIGNALING IN ENDOGENOUS NEUROPROTECTION AND STROKE
B. J. Marsh et al.
NEUROSCIENCE (2009)
Enhancement of 1,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis by calcitonin
Bryan R. Becklund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis
Monica Marta et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Analysis of the neuroinflammatory response to TLR7 stimulation in the brain: Comparison of multiple TLR7 and/or TLR8 agonists
Niranjan B. Butchi et al.
JOURNAL OF IMMUNOLOGY (2008)
Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease
J. E. Do et al.
RHEUMATOLOGY (2008)
Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis
David A. Brown et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2007)
Cutting edge: Activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides
Keith K. B. Gorden et al.
JOURNAL OF IMMUNOLOGY (2006)
Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis
Yinghua Ma et al.
JOURNAL OF CELL BIOLOGY (2006)
Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns
K Sadeghi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis
M Prinz et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis
DM Wingerchuk et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Toll-like receptors, endogenous ligands, and systemic autoimmune disease
IR Rifkin et al.
IMMUNOLOGICAL REVIEWS (2005)
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
F Heil et al.
SCIENCE (2004)
Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis
KM Spach et al.
PHYSIOLOGICAL GENOMICS (2004)
Share Paper
